Cumberland Pharmaceuticals (CPIX) Tops Q2 EPS by 15c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.08, $0.15 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.57 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• RedHill Biopharma sets $6M private placement with warrant upside
• RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement